SURAKSHA.NS

Suraksha Diagnostic Limited

HealthcareMedical - Diagnostics & ResearchININRPeers →Country macro →

$268.35

+3.35%Jun 19, 2026

AI Brief

Market cap

$13.98B

52w range

—

P / E

—

EPS · FY 2026

$6.18

Volume

—

Revenue · FY 2026

$3.1B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Suraksha Diagnostic Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$268.35

Change

-19.11%

Period high

$349.65

Period low

$227.95

Period start

$331.752025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$136.84

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

SURAKSHA.NS

268.35-19.11%

H 353.65L 224.10MA50 284.33MA200 285.36Avg vol 36K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Consumer Cyclical
+0.30%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Consumer Defensive
-0.30%
Energy
-0.45%
Industrials
-0.48%
Communication Services
-0.55%
Basic Materials
-0.66%
Real Estate
-0.99%

Top industries (issuer's industry highlighted)

Medical - Diagnostics & Research
+0.49%
Oil & Gas Energy
+8.53%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Electronic Gaming & Multimedia
+5.23%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Financial - Mortgages
+4.08%
Computer Hardware
-3.67%
Staffing & Employment Services
-3.62%
Internet Content & Information
+3.58%
Coal
-3.56%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for SURAKSHA.NS.

Peers

No peer list available for SURAKSHA.NS.

Total assets

$4.48B

Total debt

$1.3B

Cash & equiv

$263.48M

Operating CF

$841.59M

Free cash flow

$168.14M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$3.1B	$544.13M	$321.87M	$6.18	+10.37%